4 мин. чтения

Acupuncture in Oncology: Evidence for Symptom Control and Absence of Antitumor Activity

1. Introduction: A Supportive Therapy, Not an Antitumor One

Acupuncture is a component of traditional Chinese medicine in which fine needles are inserted at defined points on the body, often with electrical stimulation (electroacupuncture). In oncology it is used almost exclusively as a supportive care intervention — to relieve symptoms caused by cancer or its treatment — rather than as a treatment for the cancer itself. This distinction is essential: there is no convincing evidence that acupuncture shrinks tumors or improves cancer survival, but there is meaningful, if uneven, evidence that it can help with specific symptoms such as chemotherapy-induced nausea. This article reviews its proposed mechanisms, its evidence base, and its limits.


2. Proposed Mechanisms

Traditional explanations invoke the flow of qi along meridians. Modern research offers physiological mechanisms that do not rely on these concepts: acupuncture needling can activate sensory nerve fibers, modulate descending pain pathways, release endogenous opioids and other neurotransmitters, and influence autonomic function. Functional imaging studies show measurable central effects. These mechanisms are plausible for symptom relief; they do not imply a direct anticancer action.


3. Evidence by Symptom

3.1. Chemotherapy-Induced Nausea and Vomiting

This is acupuncture’s best-supported oncologic application. A randomized trial by Shen and colleagues found that electroacupuncture reduced chemotherapy-induced emesis compared with a control acupuncture procedure, and systematic reviews support a modest benefit when added to standard antiemetics. Major oncology guidelines include acupuncture among non-pharmacologic options for nausea and vomiting.

3.2. Pain

An individual patient data meta-analysis by Vickers and colleagues found that acupuncture was superior to sham acupuncture and to no treatment for several chronic pain conditions, though the effect is modest and partly non-specific. For cancer-related pain specifically, the evidence is more mixed, and acupuncture is used as an adjunct to analgesics rather than a replacement.

3.3. Fatigue, Hot Flashes, and Other Symptoms

Small trials and reviews suggest possible benefits for cancer-related fatigue and for hot flashes in breast cancer survivors, but results are inconsistent and the quality of evidence is generally low to moderate. For peripheral neuropathy and xerostomia, evidence is weaker still. Supportive-care guidelines list acupuncture as an option for some of these symptoms while noting the limited strength of evidence.


4. What Acupuncture Does Not Do

There is no credible evidence that acupuncture treats the underlying malignancy, prevents recurrence, or improves cancer survival. It should never be presented as an alternative to surgery, radiotherapy, systemic therapy, or other evidence-based cancer treatment. When used, it should complement — not replace — definitive therapy.


5. Safety and Practical Considerations

Serious adverse events are rare when performed by trained practitioners with sterile single-use needles. Reported complications include local bleeding or bruising, infection, and, rarely, pneumothorax with needling of the chest wall. Specific cautions apply in patients with neutropenia (infection risk), lymphedema (risk of cellulitis), coagulopathy or anticoagulation (bleeding), and implanted cardiac devices (with electroacupuncture). The main broader risk is indirect: using acupuncture as a substitute for, or a delay to, effective oncologic treatment.


6. Early Research and Emerging Approaches

  • Larger, well-blinded randomized trials of acupuncture for specific cancer symptoms (particularly fatigue and chemotherapy-induced neuropathy) are ongoing; results will refine which uses are justified.
  • Research into electroacupuncture parameters and optimal treatment schedules is continuing.

7. Unresolved Questions and Speculative Directions

  • The magnitude of benefit beyond placebo/sham for several symptoms remains uncertain. [Marked for verification.]
  • Whether acupuncture has any clinically relevant immunomodulatory effect in cancer patients is speculative and unproven.

8. Conclusion

Acupuncture is a supportive-care intervention with modest, symptom-specific evidence, best established for chemotherapy-induced nausea and vomiting and with some support for pain, fatigue, and hot flashes. It has no established role in treating cancer itself and must not replace evidence-based therapy. Performed by trained practitioners, it is generally safe, with specific cautions in neutropenic or anticoagulated patients. Its place in oncology is as a complementary tool for symptom control within a comprehensive treatment plan.


Sources and Key Research Centers

  • National Cancer Institute — PDQ summary on acupuncture.
  • National Comprehensive Cancer Network (NCCN) — supportive care guidelines listing acupuncture among non-pharmacologic options.
  • Cochrane Library — reviews of acupuncture for chemotherapy-induced nausea and vomiting and cancer pain.
  • Electroacupuncture for chemotherapy-induced emesis
    • Shen J, Wenger N, Glaspy J, et al. «Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial.» JAMA, 2000; 284(21): 2755–2761. DOI: 10.1001/jama.284.21.2755 [Verify.]
  • Acupuncture for chronic pain (individual patient data)
    • Vickers AJ, Vertosick EA, Lewith G, et al. «Acupuncture for chronic pain: update of an individual patient data meta-analysis.» The Journal of Pain, 2018; 19(5): 455–474. [Citation details to be verified.]
  • ClinicalTrials.gov — ongoing trials in cancer-related fatigue and neuropathy (search terms: acupuncture cancer fatigue, acupuncture chemotherapy neuropathy).

Note: citation identifiers are provided where available; readers should confirm bibliographic details against the publisher’s record. This article is an editorial scientific overview and is not a medical recommendation.